Life Tech Sues Illumina Over DNA Device Patents

Law360, New York (May 25, 2010, 7:30 PM EDT) -- Biotechnology tools maker Life Technologies Corp. has filed a suit against Illumina Inc., claiming its genetic analysis products infringe eight patents covering methods and instruments for DNA and RNA sequencing.

Patent licensee Life Technologies joined its subsidiary Applied Biosystems LLC and patent owner Cornell University and the school's research foundation in lodging a complaint Monday in the U.S. District Court for the District of Delaware.

Life Technologies, which says it holds the exclusive rights to the patents-in-suit, claims Illumina has infringed at least one claim of...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.